➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
Dow
Mallinckrodt
McKesson
Baxter

Last Updated: September 27, 2021

DrugPatentWatch Database Preview

Details for Biologics License Application: 761053


Email this page to a colleague

« Back to Dashboard

Summary for BLA: 761053
Tradename:OCREVUS
Applicant:Genentech Inc
Ingredient:ocrelizumab
Patents:70
Approval Date:Mar 28, 2017
Suppliers: see list1

US Patents for BLA: 761053

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech Inc OCREVUS ocrelizumab INJECTABLE;INJECTION 761053 001 2017-03-28 ⤷  Try it Free SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) 2033-03-11 RX search
Genentech Inc OCREVUS ocrelizumab INJECTABLE;INJECTION 761053 001 2017-03-28 ⤷  Try it Free The United States of America, as represented by the Secretary, Department of Health and Human Services (Washington, DC) University of Virginia Patent Foundation (Charlottesville, VA) 2034-01-08 RX search
Genentech Inc OCREVUS ocrelizumab INJECTABLE;INJECTION 761053 001 2017-03-28 ⤷  Try it Free ALDERBIO HOLDINGS LLC (Las Vegas, NV) 2028-11-25 RX search
Genentech Inc OCREVUS ocrelizumab INJECTABLE;INJECTION 761053 001 2017-03-28 ⤷  Try it Free CureVac AG (Tubingen, DE) 2032-02-15 RX search
Genentech Inc OCREVUS ocrelizumab INJECTABLE;INJECTION 761053 001 2017-03-28 ⤷  Try it Free FUNDACIO INSTITUT D\'INVESTIGACIO BIOM DICA DE BELLVITGE (IDIBELL) (Barcelona, ES) 2039-03-23 RX search
Genentech Inc OCREVUS ocrelizumab INJECTABLE;INJECTION 761053 001 2017-03-28 ⤷  Try it Free UNIVERSITY OF UTAH RESEARCH FOUNDATION (Salt Lake City, GA) 2033-03-12 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
AstraZeneca
Boehringer Ingelheim
Dow
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.